Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE study
Colorectal cancer (CRC) is the second most common cause of death due to cancer causing death in Europe, accounting for more than 200,000 deaths per year. Prognosis strongly depends on stage at diagnosis, and the disease can be cured in most cases if diagnosed at an early stage. We aimed to assess tr...
Saved in:
Published in | International journal of cancer Vol. 131; no. 7; pp. 1649 - 1658 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.10.2012
Wiley-Blackwell Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Colorectal cancer (CRC) is the second most common cause of death due to cancer causing death in Europe, accounting for more than 200,000 deaths per year. Prognosis strongly depends on stage at diagnosis, and the disease can be cured in most cases if diagnosed at an early stage. We aimed to assess trends and recent developments in 5‐year relative survival in European countries, with a special focus on age, stage at diagnosis and anatomical cancer subsite. Data from 25 population‐based cancer registries from 16 European countries collected in the context of the EUROCARE‐4 project were analyzed. Using period analysis, age‐adjusted and age‐specific 5‐year relative survival was calculated by country, European region, stage and cancer subsite for time periods from 1988–1990 to 2000–2002. Survival substantially increased over time in all European regions. In general, increases were more pronounced in younger than in older patients, for earlier than for more advanced cancer stages and for rectum than for colon cancer. Substantial variation of CRC survival between European countries and between age groups persisted and even tentatively increased over time. There is a huge potential for reducing the burden of CRC in Europe by more widespread and equal delivery of existing options of effective early detection and curative treatment to the European population. |
---|---|
Bibliography: | ArticleID:IJC26192 ark:/67375/WNG-THJWF9LK-L istex:356B1DD98B98A40D3716D35463E79478F359FBA0 Compagnia di S Paolo di Torino The Netherlands J. Faivre, A.M. Bouvier (Côte d'Or Digestive Cancer Registry) F. Berrino, C. Allemani, P. Baili, R. Ciampichini, L. Ciccolallo, G. Gatta, A. Micheli, M. Sant, S. Sowe, G. Zigon (Fondazione IRCCS; “Istituto Nazionale dei Tumori”, Milan, Italy); M. Caldora, R. Capocaccia, E. Carrani, R. De Angelis, S. Francisci, E. Grande, R. Inghelmann, H. Lenz, L. Martina, P. Roazzi, M. Santaquilani, A. Simonetti, A. Tavilla, A. Verdecchia (Istituto Superiore di Sanitá, Rome, Italy); M. Vercelli, M.A. Orengo, C. Casella, A. Quaglia (Liguria Cancer Registry, IST/Univ. Genova); M. Michiara, F. Bozzani (Parma Cancer Registry); R. Tumino, M.G. La Rosa, E. Spata, A. Sigona (Cancer Registry Azienda Ospedaliera “Civile M.P.Arezzo” Ragusa, Italy); F. Falcini, F. Foca, S. Giorgetti (Romagna Cancer Registry‐I.R.S.T); R. Zanetti, S. Patriarca, S. Rosso (Torino Cancer Registry); E. Crocetti, C. Buzzoni (Tuscan Cancer Registry) M. Primic‐Žakelj (Cancer Registry of Slovenia) J.W.W. Coebergh, M.L. Janssen‐Heijnen, Louis van der Heijden (Eindhoven Cancer Registry) L. Tryggvadottir (Icelandic Cancer Registry) S. Khan, M. Talbäck (Cancer Registry of Sweden) D.C. Greenberg (East Anglia); N. Easey (Northern and Yorkshire Cancer Registry and Information Service); M. Roche (Oxford Cancer Intelligence Unit); G. Lawrence (West Midlands Cancer Intelligence Unit) Iceland G. Jundt (Basel Cancer Registry); M. Usel, C. Bouchardy (Geneva Cancer Registry) Austria Sweden M. Ondrusova (National Cancer Registry of the Slovak Republic and Cancer Research Institute of the Slovak Academy of Sciences) Poland Slovakia Slovenia France J.A. Steward (Welsh Cancer Intelligence and Surveillance Unit). UK, England Tel: +49‐6221‐548140, Fax: +49‐6221‐548142 H. Brenner (German Cancer Research Center, Heidelberg, Germany); B. Holleczek (Saarland Cancer Registry) T. Hakulinen (Finnish Cancer Registry) Switzerland R.J. Black, D.H. Brewster (Scottish Cancer Registry) Members of EUROCARE Working Group UK, Wales Norway J. Rachtan (Cracow Cancer Registry) M. Hackl, N. Zielonk (Austrian National Cancer Registry) Finland Italy F. Langmark, F. Bray, T.B. Johannesen (Cancer Registry of Norway) UK, Scotland Germany ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0020-7136 1097-0215 |
DOI: | 10.1002/ijc.26192 |